quinidine has been researched along with formononetin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Ahmad, K; Ahmad, SS; Alam, Q; Alnamshan, MM; Alqosaibi, AI; Alshamrani, S; Bahnass, MM; Beg, MMA; Chaturvedi, N; Mashraqi, MM; Mishra, A; Rizvi, SMD; Shaikh, S | 1 |
2 other study(ies) available for quinidine and formononetin
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Biocomputational Prediction Approach Targeting FimH by Natural SGLT2 Inhibitors: A Possible Way to Overcome the Uropathogenic Effect of SGLT2 Inhibitor Drugs.
Topics: Adhesins, Escherichia coli; Computational Biology; Computer Simulation; Coumarins; Diabetes Mellitus, Type 2; Escherichia coli Infections; Fimbriae Proteins; Humans; Isoflavones; Molecular Docking Simulation; Quinidine; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Urinary Tract Infections; Uropathogenic Escherichia coli | 2021 |